Safety and Efficacy of Itacitinib in Combination With Corticosteroids for Treatment of Graft-Versus-Host Disease in Pediatric Subjects
Clinical trial NCT03721965 · TERMINATED
Trial details
- NCT number
- NCT03721965
- Sponsor
- Incyte Corporation
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-31
- Primary completion
- 2020-02-17
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.